These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 33990328)

  • 21. Two-stage cooperative T cell receptor-peptide major histocompatibility complex-CD8 trimolecular interactions amplify antigen discrimination.
    Jiang N; Huang J; Edwards LJ; Liu B; Zhang Y; Beal CD; Evavold BD; Zhu C
    Immunity; 2011 Jan; 34(1):13-23. PubMed ID: 21256056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insights from in situ analysis of TCR-pMHC recognition: response of an interaction network.
    Zhu C; Jiang N; Huang J; Zarnitsyna VI; Evavold BD
    Immunol Rev; 2013 Jan; 251(1):49-64. PubMed ID: 23278740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of serial engagement and peptide-MHC transport in T cell receptor microclusters.
    Dushek O; Coombs D
    Biophys J; 2008 May; 94(9):3447-60. PubMed ID: 18227132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The versatility of the αβ T-cell antigen receptor.
    Bhati M; Cole DK; McCluskey J; Sewell AK; Rossjohn J
    Protein Sci; 2014 Mar; 23(3):260-72. PubMed ID: 24375592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deciphering Membrane-Protein Interactions and High-Throughput Antigen Identification with Cell Doublets.
    Wang Y; Wang Z; Yang J; Lei X; Liu Y; Frankiw L; Wang J; Li G
    Adv Sci (Weinh); 2024 Apr; 11(13):e2305750. PubMed ID: 38342599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody specific for the peptide.major histocompatibility complex. Is it T cell receptor-like?
    Mareeva T; Lebedeva T; Anikeeva N; Manser T; Sykulev Y
    J Biol Chem; 2004 Oct; 279(43):44243-9. PubMed ID: 15302863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting TCR-Epitope Binding Specificity Using Deep Metric Learning and Multimodal Learning.
    Luu AM; Leistico JR; Miller T; Kim S; Song JS
    Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33920780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unraveling the Allosteric Communication Mechanisms in T-Cell Receptor-Peptide-Loaded Major Histocompatibility Complex Dynamics Using Molecular Dynamics Simulations: An Approach Based on Dynamic Cross Correlation Maps and Residue Interaction Energy Calculations.
    Bingöl EN; Serçinoğlu O; Ozbek P
    J Chem Inf Model; 2021 May; 61(5):2444-2453. PubMed ID: 33930270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Full Model of the pMHC-TCR-CD3 Complex: A Structural and Dynamical Characterization of Bound and Unbound States.
    Alba J; D'Abramo M
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normalized Synergy Predicts That CD8 Co-Receptor Contribution to T Cell Receptor (TCR) and pMHC Binding Decreases As TCR Affinity Increases in Human Viral-Specific T Cells.
    Williams CM; Schonnesen AA; Zhang SQ; Ma KY; He C; Yamamoto T; Eckhardt SG; Klebanoff CA; Jiang N
    Front Immunol; 2017; 8():894. PubMed ID: 28804489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Viral Escape Mutant Epitope Maintains TCR Affinity for Antigen yet Curtails CD8 T Cell Responses.
    Shorter SK; Schnell FJ; McMaster SR; Pinelli DF; Andargachew R; Evavold BD
    PLoS One; 2016; 11(2):e0149582. PubMed ID: 26915099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation of peptide-MHC and T-cell receptor dextramers by biotinylated dextran doping.
    Bethune MT; Comin-Anduix B; Hwang Fu YH; Ribas A; Baltimore D
    Biotechniques; 2017 Mar; 62(3):123-130. PubMed ID: 28298179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suboptimal engagement of the T-cell receptor by a variety of peptide-MHC ligands triggers T-cell anergy.
    Sadegh-Nasseri S; Dalai SK; Korb Ferris LC; Mirshahidi S
    Immunology; 2010 Jan; 129(1):1-7. PubMed ID: 20002785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional evidence for TCR-intrinsic specificity for MHCII.
    Parrish HL; Deshpande NR; Vasic J; Kuhns MS
    Proc Natl Acad Sci U S A; 2016 Mar; 113(11):3000-5. PubMed ID: 26831112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unresponsiveness to a self-peptide of mouse lysozyme owing to hindrance of T cell receptor-major histocompatibility complex/peptide interaction caused by flanking epitopic residues.
    Moudgil KD; Grewal IS; Jensen PE; Sercarz EE
    J Exp Med; 1996 Feb; 183(2):535-46. PubMed ID: 8627165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stress-testing the relationship between T cell receptor/peptide-MHC affinity and cross-reactivity using peptide velcro.
    Gee MH; Sibener LV; Birnbaum ME; Jude KM; Yang X; Fernandes RA; Mendoza JL; Glassman CR; Garcia KC
    Proc Natl Acad Sci U S A; 2018 Jul; 115(31):E7369-E7378. PubMed ID: 30021852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluctuations in T cell receptor and pMHC interactions regulate T cell activation.
    Egan JR; Abu-Shah E; Dushek O; Elliott T; MacArthur BD
    J R Soc Interface; 2022 Feb; 19(187):20210589. PubMed ID: 35135295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How TCRs bind MHCs, peptides, and coreceptors.
    Rudolph MG; Stanfield RL; Wilson IA
    Annu Rev Immunol; 2006; 24():419-66. PubMed ID: 16551255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HeteroTCR: A heterogeneous graph neural network-based method for predicting peptide-TCR interaction.
    Yu Z; Jiang M; Lan X
    Commun Biol; 2024 Jun; 7(1):684. PubMed ID: 38834836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantifying the strength of ligand antagonism in TCR triggering.
    Van Den Berg HA; Burroughs NJ; Rand DA
    Bull Math Biol; 2002 Jul; 64(4):781-808. PubMed ID: 12216421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.